Journal
NEUROPSYCHOLOGY REVIEW
Volume 17, Issue 3, Pages 317-336Publisher
SPRINGER
DOI: 10.1007/s11065-007-9033-y
Keywords
cognition; executive function; substance abuse; amphetamines; opiates; cognitive enhancement
Categories
Funding
- Medical Research Council [G0001354B] Funding Source: researchfish
- Medical Research Council [G0001354] Funding Source: Medline
- Wellcome Trust [019407] Funding Source: Medline
Ask authors/readers for more resources
Chronic use of amphetamines and/or opiates has been associated with a wide range of cognitive deficits, involving domains of attention, inhibitory control, planning, decision-making, learning and memory. Although both amphetamine and opiate users show marked impairment in various aspects of cognitive function, the impairment profile is distinctly different according to the substance of abuse. In light of evidence showing that cognitive impairment in drug users has a negative impact on treatment engagement and efficacy, we review substance-specific deficits on executive and memory function, and discuss possibilities to address these during treatment intervention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available